Clinical trial
A Real-world Study on the Efficacy and Safety of Menin Inhibitors as Maintenance Therapy After Allogeneic Hematopoietic Stem Cell Transplantation
NCT07559695 is registered in ClinicalTrials.gov with The First Affiliated Hospital of Soochow University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Real-world Study on the Efficacy and Safety of Menin Inhibitors as Maintenance Therapy After Allogeneic Hematopoietic Stem Cell Transplantation
- Lead sponsor
- The First Affiliated Hospital of Soochow University
- Phase
- Observational
- Overall status
- Recruiting
- Start date
- November 1, 2025
- Completion date
- December 31, 2029
- Enrollment
- 20 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
acute leukemia, kmt2a rearrangement, maintenance therapy, menin inhibitors, npm1 mutation, nup98 gene rearrangement, post hematopoietic stem cell transplantation